Skip to content

Understanding What are the Diseases Associated with Calcification?

4 min read

Approximately 10% of women under 50 and about half of women over 50 have breast calcifications, showing how common the phenomenon can be. However, when calcium deposits build up abnormally in soft tissues, they can lead to serious health problems. Understanding what are the diseases associated with calcification is key to managing the underlying conditions.

Quick Summary

Calcification occurs when calcium builds up in soft tissues and organs, signaling conditions ranging from cardiovascular issues and kidney disease to autoimmune disorders and genetic syndromes.

Key Points

  • Arterial Calcification: Often a sign of atherosclerosis, the hardening and stiffening of arteries, increasing cardiovascular risk.

  • Dystrophic vs. Metastatic: Calcification can occur in damaged tissue with normal mineral levels (dystrophic) or in healthy tissue with abnormal blood calcium/phosphate levels (metastatic).

  • Renal Damage: Conditions like nephrocalcinosis and kidney stones involve calcium deposits in the kidney tissue and urinary tract, potentially damaging kidney function.

  • Autoimmune Links: Dystrophic calcification, or calcinosis cutis, is a common feature in connective tissue diseases like scleroderma and dermatomyositis.

  • Mammogram Findings: The presence of breast calcifications on a mammogram is common and usually benign, but certain patterns can indicate early breast cancer.

  • Genetic Origins: Some rare diseases, such as generalized arterial calcification of infancy (GACI) and familial tumoral calcinosis, are caused by genetic mutations affecting mineral regulation.

  • Joint and Tendon Problems: Calcium deposits in joints (CPPD disease) or tendons (calcific tendonitis) can cause significant pain and inflammation.

In This Article

What is Calcification?

Calcification is the buildup of calcium salts in soft body tissues where they do not normally belong. This mineralization can harden and disrupt normal bodily functions. Calcification is often a natural part of the body's repair or aging processes, occurring in response to injury, cell death, or inflammation. However, depending on the location, size, and type of deposit, it can indicate a significant underlying disease.

There are two main types of ectopic (abnormal) calcification:

  • Dystrophic calcification: The most common form, occurring in damaged or dead tissues with normal blood calcium and phosphate levels. It is an inflammatory response seen in areas of trauma, infection, and autoimmune disorders.
  • Metastatic calcification: Occurs in normal tissues due to an overabundance of calcium in the bloodstream (hypercalcemia), which can be caused by various metabolic disorders.

Cardiovascular Diseases

Calcification in the cardiovascular system is a major health concern, often associated with age, diabetes, and atherosclerosis. The hardening and stiffening of blood vessels and heart valves can have life-threatening consequences.

Atherosclerosis

Atherosclerosis is a chronic inflammatory disease where fatty plaques accumulate inside artery walls. Calcification is a common feature of these plaques, and the extent of coronary artery calcification (CAC) is a reliable indicator of the overall atherosclerotic burden. While large, stable calcified plaques may offer some structural stability, microcalcifications within thin fibrous caps are associated with increased plaque rupture risk, a cause of heart attacks. Conditions that accelerate atherosclerosis, such as chronic kidney disease (CKD) and diabetes, also exacerbate vascular calcification.

Heart Valve Disease

Calcific aortic valve disease is a common valve disorder in the elderly, where calcium deposits accumulate and harden the heart's valves. This can obstruct blood flow from the heart, leading to aortic stenosis, a condition that can result in heart failure. While this was once considered a passive degenerative process, it is now understood to be an active inflammatory process, similar to atherosclerosis.

Calciphylaxis

Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare but life-threatening syndrome involving the calcification of small and medium-sized blood vessels in the skin and fatty tissue. It is most often seen in patients with end-stage renal disease (ESRD) and can lead to painful skin ulcers and necrosis.

Renal and Urinary System Diseases

The kidneys are crucial for filtering waste and regulating minerals. Disruption of this process can lead to significant calcification issues.

Nephrocalcinosis

Nephrocalcinosis is the deposition of calcium salts in the kidney tissue (parenchyma), rather than inside the collecting system like kidney stones. It is frequently associated with high levels of calcium or oxalate in the blood or urine, often as a result of underlying metabolic disorders, genetic syndromes, or certain medications. Conditions like renal tubular acidosis and primary hyperoxaluria can be culprits.

Kidney Stones (Nephrolithiasis)

Kidney stones are solid masses formed from crystals, predominantly calcium oxalate, that separate from the urine. These stones form within the urinary tract and can cause severe pain as they pass. High levels of urinary calcium, oxalate, or phosphate, along with insufficient fluid intake, are primary risk factors.

Connective Tissue and Musculoskeletal Disorders

Calcification can occur within the body's supporting structures, such as skin, tendons, and joints, as part of an inflammatory or autoimmune process.

Calcinosis Cutis

This condition involves calcium deposits in the skin and subcutaneous tissue. It is a form of dystrophic calcification often linked to autoimmune diseases like systemic sclerosis (scleroderma), dermatomyositis, and lupus. Calcinosis cutis can lead to painful nodules and skin ulcerations, particularly around joints and pressure points.

Calcific Tendonitis

This is a condition where calcium deposits form in the tendons, most commonly the rotator cuff tendons in the shoulder. It can cause inflammation and significant pain, particularly during movement. The deposits can vary from a soft, paste-like consistency to a hard, bone-like material.

Calcium Pyrophosphate Deposition (CPPD) Disease

Also known as pseudogout, CPPD disease involves the formation and accumulation of calcium pyrophosphate crystals in the cartilage and joints. This can lead to attacks of painful joint inflammation, mimicking gout, or a more chronic arthritis.

Breast Calcifications

Breast calcifications are tiny calcium deposits often found on mammograms. They are typically harmless, but their size, shape, and pattern can help determine if a biopsy is needed.

Macrocalcifications

These appear as large, coarse white dots or dashes and are almost always non-cancerous. They require no further investigation.

Microcalcifications

These appear as fine, white specks. While often benign, certain patterns (e.g., clustered microcalcifications) can indicate the early stages of breast cancer and necessitate further testing.

Genetic and Metabolic Disorders

Generalized Arterial Calcification of Infancy (GACI)

A rare, and often fatal, genetic disorder causing widespread calcification of large and medium-sized arteries in infants. It is caused by mutations in genes (ENPP1 or ABCC6) that disrupt the regulation of pyrophosphate, an inhibitor of calcification.

Primary Familial Brain Calcification

This genetic disorder causes calcification in the basal ganglia of the brain, affecting movement control. Symptoms can include tremors, unsteady gait, and psychiatric problems.

Hyperphosphatemic Familial Tumoral Calcinosis (HFTC)

A rare genetic condition characterized by high phosphate levels in the blood and massive, tumor-like calcified deposits around major joints. The deposits are non-cancerous but can impair movement.

Conclusion

Calcification is a broad term for the abnormal deposition of calcium salts in soft tissues. It can be a harmless finding or a symptom of a serious disease. From common cardiovascular and kidney conditions to rarer genetic syndromes and autoimmune disorders, calcification is a marker or component of numerous pathologies. Identifying the underlying cause—be it tissue damage, metabolic imbalance, or genetic predisposition—is critical for proper diagnosis and management. The relationship between inflammation, mineral regulation, and cellular processes is key to understanding and potentially treating these diverse diseases. For more detailed information on specific conditions, consult an authoritative medical resource such as the National Institutes of Health (NIH) MedlinePlus website.

Frequently Asked Questions

No. While some calcifications can indicate serious conditions like heart disease or kidney problems, many are harmless and part of the normal aging or healing process. For example, some breast calcifications found on mammograms are benign.

Nephrocalcinosis involves calcium deposits in the kidney tissue itself, specifically the renal parenchyma. Kidney stones (nephrolithiasis), on the other hand, are solid masses that form inside the urinary tract from crystallized minerals.

The reversibility of calcification depends on the location and cause. While some deposits, like those in calcific tendonitis, may spontaneously resorb over time, others, particularly in heart valves and arteries, are generally considered permanent. Treatment focuses on managing the underlying cause and related complications.

Vascular calcification is caused by a complex process involving inflammation and deposits in the artery wall. It is associated with aging, atherosclerosis, chronic kidney disease, and metabolic disorders like diabetes.

No. Microcalcifications on a mammogram appear as fine white specks. While certain patterns can be an early sign of cancer, most are benign. Further testing is necessary to determine their significance.

Several autoimmune diseases can cause calcinosis cutis, including systemic sclerosis (scleroderma), dermatomyositis, and systemic lupus erythematosus.

GACI is a rare and severe genetic disorder causing widespread arterial calcification in infants, often leading to death within the first six months of life. However, some infants survive and may be treated with bisphosphonates to increase survival rates.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.